Related Experiment Video
Updated: Jan 7, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Non-traditional cardiovascular risk factors after kidney transplantation
Amer Ashaab Belal1, Alfonso H Santos2, Amir Kazory2
1Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida College of Medicine, Gainesville, FL 32610, United States. abelal@ufl.edu.
Insights
Kidney transplant recipients face significant cardiovascular risks beyond traditional factors. This review details transplant-specific risks, immunosuppression effects, and considerations for special populations to improve long-term outcomes.
Area of Science:
- Nephrology
- Cardiology
- Transplantation Medicine
Background:
- Kidney transplantation is the optimal treatment for end-stage kidney disease.
- Cardiovascular disease (CVD) is the primary cause of mortality in kidney transplant recipients.
- Traditional CVD risk factors are common but often exacerbated by transplant-specific issues.
Purpose of the Study:
- To review non-traditional and transplant-related cardiovascular risk factors in kidney transplant recipients.
- To examine the cardiovascular implications of immunosuppressive therapy and associated infections.
- To discuss considerations for special populations regarding non-traditional CVD risks.
Main Methods:
- Literature review of current understanding of cardiovascular risks in kidney transplant recipients.
- Analysis of transplant-specific factors contributing to cardiovascular disease.
- Examination of immunosuppression-related complications and their cardiovascular impact.
Main Results:
- Kidney transplant recipients experience unique cardiovascular risks including allograft dysfunction and rejection.
- Immunosuppressive therapy contributes to cardiovascular risk and opportunistic infections like cytomegalovirus.
- Data on non-traditional cardiovascular risks in special populations of transplant recipients is evolving.
Conclusions:
- Addressing non-traditional cardiovascular risk factors is crucial for improving survival post-kidney transplantation.
- Understanding the interplay between immunosuppression, infection, and cardiovascular health is vital.
- Further research is needed to optimize cardiovascular care for diverse kidney transplant recipient populations.
Abstract:
Kidney transplantation remains the best treatment option for patients with end-stage kidney disease, offering superior outcomes and improved quality of life. However, as in the general population, cardiovascular disease remains the leading cause of mortality among kidney transplant recipients. While traditional cardiovascular risk factors-such as hypertension, diabetes, dyslipidemia, and tobacco use-are prevalent in this population, they are often compounded by transplant-specific and non-traditional risk factors unique to the post-transplant setting. This review aims to explore these non-traditional and transplant-related cardiovascular risk factors, including allograft dysfunction and acute rejection episodes. Moreover, we will provide an overview of the cardiovascular implications of immunosuppressive therapy, including its association with opportunistic infections such as cytomegalovirus. Finally, we will touch upon considerations for special populations of kidney transplant recipients based on our current understanding of these non-traditional cardiovascular risks with the currently available data.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations

